# Investigating Cardiovascular Adverse Events Related to Cancer Treatment

> **NCT03199300** · — · ACTIVE_NOT_RECRUITING · sponsor: **University Medical Center Groningen** · enrollment: 20 (actual)

## Conditions studied

- Toxicity Due to Chemotherapy
- Cardiovascular Morbidity
- Cancer, Treatment-Related

## Interventions

- **DRUG:** Anthracyclines
- **DRUG:** Trastuzumab
- **DRUG:** Cisplatin
- **DRUG:** Bleomycin

## Key facts

- **NCT ID:** NCT03199300
- **Lead sponsor:** University Medical Center Groningen
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2017-12-12
- **Primary completion:** 2025-02-06
- **Final completion:** 2027-01
- **Target enrollment:** 20 (ACTUAL)
- **Last updated:** 2025-12-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03199300

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03199300, "Investigating Cardiovascular Adverse Events Related to Cancer Treatment". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT03199300. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*